Benzinga | Mar 30, 2021 04:08PM EDT

Arcadia Biosciences Q4 EPS $(0.47) Misses $(0.41) Estimate, Sales $7.13M Beat $1.26M Estimate

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.41) by 14.63 percent. This is a 34.72 percent increase over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $7.13 million which beat the analyst consensus estimate of $1.26 million by 465.87 percent. This is a 1.61K percent increase over sales of $416.00 thousand the same period last year.